» Articles » PMID: 30104296

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2018 Aug 15
PMID 30104296
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetes mellitus (DM) increases the risk of infections, but the effect of better control has not been thoroughly investigated.

Research Design And Methods: With the use of English primary care data, average glycated hemoglobin (HbA) during 2008-2009 was estimated for 85,312 patients with DM ages 40-89 years. Infection rates during 2010-2015 compiled from primary care, linked hospital, and mortality records were estimated across 18 infection categories and further summarized as any requiring a prescription or hospitalization or as cause of death. Poisson regression was used to estimate adjusted incidence rate ratios (IRRs) by HbA categories across all DM, and type 1 and type 2 DM separately. IRRs also were compared with 153,341 age-sex-practice-matched controls without DM. Attributable fractions (AF%) among patients with DM were estimated for an optimal control scenario (HbA 6-7% [42-53 mmol/mol]).

Results: Long-term infection risk rose with increasing HbA for most outcomes. Compared with patients without DM, those with DM and optimal control (HbA 6-7% [42-53 mmol/mol], IRR 1.41 [95% CI 1.36-1.47]) and poor control (≥11% [97 mmol/mol], 4.70 [4.24-5.21]) had elevated hospitalization risks for infection. In patients with type 1 DM and poor control, this risk was even greater (IRR 8.47 [5.86-12.24]). Comparisons within patients with DM confirmed the risk of hospitalization with poor control (2.70 [2.43-3.00]) after adjustment for duration and other confounders. AF% of poor control were high for serious infections, particularly bone and joint (46%), endocarditis (26%), tuberculosis (24%), sepsis (21%), infection-related hospitalization (17%), and mortality (16%).

Conclusions: Poor glycemic control is powerfully associated with serious infections and should be a high priority.

Citing Articles

Rapidly Progressive Pyogenic Ventriculitis Associated With Bacterial Meningitis Caused by Streptococcus intermedius.

Matsubayashi T, Arai Y, Obayashi M Cureus. 2025; 17(1):e77843.

PMID: 39991394 PMC: 11845238. DOI: 10.7759/cureus.77843.


Diabetes potentiates the emergence and expansion of antibiotic resistance.

Shook J, Genito C, Darwitz B, Tyson K, Velez A, Bridwell S Sci Adv. 2025; 11(7):eads1591.

PMID: 39937900 PMC: 11817934. DOI: 10.1126/sciadv.ads1591.


Unravelling the cardio-renal-metabolic-foot connection in people with diabetes-related foot ulceration: a narrative review.

Lan N, Dwivedi G, Fegan P, Game F, Hamilton E Cardiovasc Diabetol. 2024; 23(1):437.

PMID: 39696281 PMC: 11657306. DOI: 10.1186/s12933-024-02527-1.


Glycemic control and bacterial infectious risk in type 2 diabetes: A retrospective cohort from a primary care database.

Lemoine E, Dusenne M, Schuers M PLoS One. 2024; 19(12):e0314287.

PMID: 39671462 PMC: 11642988. DOI: 10.1371/journal.pone.0314287.


Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.

Kristensen F, Domazet S, Nielsen J, Stidsen J, Hojlund K, Beck-Nielsen H Diabetologia. 2024; 68(3):576-587.

PMID: 39663235 DOI: 10.1007/s00125-024-06342-x.